Compare WAFU & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WAFU | HKPD |
|---|---|---|
| Founded | 1999 | 2016 |
| Country | China | Hong Kong |
| Employees | N/A | 27 |
| Industry | Other Consumer Services | Other Pharmaceuticals |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 6.9M |
| IPO Year | 2017 | N/A |
| Metric | WAFU | HKPD |
|---|---|---|
| Price | $1.65 | $0.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.9K | ★ 79.0K |
| Earning Date | 07-31-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.36 | $0.37 |
| 52 Week High | $2.17 | $2.74 |
| Indicator | WAFU | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 49.48 | 41.02 |
| Support Level | $1.63 | $0.41 |
| Resistance Level | $1.73 | $0.71 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 25.00 | 38.88 |
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.